𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risk factors for cytomegalovirus infection and disease in renal transplant recipients: HLA-DR7 and triple therapy

✍ Scribed by Y. J. Kraat; M. H. L. Christiaans; F. H. M. Nieman; P. M. Berg-Loonen; J. P. Hooff; C. A. Bruggeman

Publisher
Springer
Year
1994
Tongue
English
Weight
536 KB
Volume
7
Category
Article
ISSN
0934-0874

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HLA mismatching and cytomegalovirus infe
HLA mismatching and cytomegalovirus infection as risk factors for transplant failure in cyclosporin-treated renal allograft recipients
✍ Dr. David J. Morris; Susan Martin; Philip A. Dyer; Linda Hunt; Netar P. Mallick; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB

## Abstract In a study of the effects on renal allograft survival of HLA mismatching, mismatching for cytomegalovirus (CMV) antibody status, and post‐transplant CMV infection, 148 cyclosporin‐treated renal transplant recipients were given kidneys optimally matched for HLA‐A, ‐B, and ‐DR antigens bu

Risk factors for malignancy in Japanese
Risk factors for malignancy in Japanese renal transplant recipients
✍ Tetsuya Imao; Naotsugu Ichimaru; Shiro Takahara; Yukito Kokado; Masayoshi Okumi; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

## Abstract ## BACKGROUND. Among recipients of renal transplants, the incidences of renal cancer and gastrointestinal cancer are higher and that of skin cancer is much lower in Japan than in Europe and North America. ## METHODS. The risk factors for the development of malignant tumors were exami

IgM antibody detection of ppUL80a and pp
IgM antibody detection of ppUL80a and ppUL32 by immunoblotting: An early parameter for recurrent cytomegalovirus infection in renal transplant recipients
✍ Kraat, Y.J.; Stals, F.S.; Christiaans, M.H.; Lazzarotto, T.; Landini, M.P.; Brug 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 678 KB

The value of IgM detection for the early diagnosis of an active cytomegalovirus (CMV) infection in renal transplant recipients was evaluated prospectively. Sequential serum samples obtained from 22 allograft recipients with active CMV infection were tested for the presence of CMV-specific immunoglob